Oct 15, 2026
Neuvera has launched its Skin Lift & Repair Routine, pairing two moisturizer textures powered by Peptide G63 as research continues to explore topical peptides for skin barrier and inflammation support.

Hanover, United States, October 15, 2026 /PressCable/ -- As peptide-based skincare draws growing interest for its potential role in skin barrier support and inflammatory signaling, Neuvera has launched its Skin Lift & Repair Routine, pairing PeptiLIFT™ and PeptiPROTECT™ in a simplified two-step system. The new bundle brings the company’s Peptide G63™ technology into two complementary moisturizer textures, giving consumers lightweight daily moisture and richer replenishment within the same routine.
Research is adding to broader interest in the relationship between topical peptides, skin barrier function, hydration, and inflammatory signaling. In a 2025 randomized controlled trial published in the Journal of Cosmetic Dermatology, researchers evaluated a topical peptide formulation in a pilot study of 60 women aged 60 to 90. After 12 weeks, the formulation was associated with improvements in skin barrier function and hydration, along with a reduction in the pro-inflammatory marker IL-8 measured in blood. The findings add to the growing research interest in peptide-based approaches to skin health, while providing broader context for ongoing research into how peptide formulations may influence skin function and inflammatory signaling.
Neuvera’s Skin Lift & Repair Routine centers on Peptide G63, the company’s signaling-peptide technology shared by both moisturizers. Keeping the peptide foundation consistent while changing the moisturizer texture allows users to adjust the level of moisture and comfort according to how their skin feels.
“Skin does not necessarily need the same level of moisture every day or throughout the year,” said Deborah Archer, MD, Neuvera Chief Medical Advisor. “Using two complementary moisturizer textures gives people flexibility to respond to those changing needs while keeping the underlying peptide technology consistent.”
PeptiLIFT provides the lightweight option in the routine. The daily moisturizer is formulated to support a firmer, smoother-looking finish while delivering moisture without the feel of a heavier cream.
PeptiPROTECT offers richer, replenishing moisture for skin that feels dry, depleted, or in need of additional comfort. The two moisturizers can be used individually or together, allowing users to choose a texture according to their skin needs, environment, and personal preference.
The bundle follows a straightforward approach: one peptide technology, two moisturizer textures, one simple routine. By pairing lightweight daily moisture with a richer replenishing option, Neuvera is extending its Peptide G63 topical range without adding unnecessary complexity to everyday skincare.
About Neuvera
Neuvera is a biotechnology-led skincare and wellness startup built around the patented Peptide G portfolio developed by scientist Sean Shelby. The company combines peptide science with accessible daily wellness. Neuvera currently serves consumers across the United States through its direct-to-consumer platform.
More information about Neuvera and its Peptide G63 topical range is available at https://neuveralife.com/peptide-g63-topicals
Contact Info:
Name: Cody Nickson
Email: Send Email
Organization: Neuvera
Address: 3 Wing Dr Cedar Knolls, Hanover, New Jersey 07927, United States
Website: https://neuveralife.com/
Source: PressCable
Release ID: 89206271
Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.
Sir Cliff Richard has revealed his prostate cancer "isn't even detectable" anymore after he underwent treatment for the disease last year.
Bill Skarsgard has confessed he uses the voice of his terrifying IT character Pennywise when his kids are "misbehaving".
Lamar Odom has revealed he has already made over $50,000 in just over a week on OnlyFans.
Police were called after a man was stabbed at Jamie Foxx's annual Halloween party.
Protesters at a pre-election rally for arts funding say financial support for the sector is shrinking - and arts workers are leaving.
Andy Serkis has revealed that the challenge of playing Gollum again in upcoming movie The Lord of the Rings: The Hunt for Gollum is keeping him up at night.
James Bond director Denis Villeneuve teased film fans about the announcement of the next 007 during an appearance at the LACMA Art and Film Gala in Los Angeles on Saturday (07.11.26).
Deep Purple frontman Ian Gillan is recovering after undergoing "successful" surgery after a health crisis prompted the band to call off the remaining dates of the European leg of their Splat! world tour.
The ultimate showcase of Western Australia’s next big musical exports is taking over Burswood Park this month.
Michael J. Fox feared he would be "crucified" for making light of his Parkinson's disease battle when he appeared on Larry David's sitcom Curb Your Enthusiasm in 2011.
Former US President Joe Biden has admitted his battle with cancer has "slowed" him down and "some days after better than others" but his doctors are "encouraged" by how he has responded to treatment.
US President Donald Trump claims that he was "kidding" about offering the role of White House press secretary to UFC boss Dana White.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.